All Posts

Soleno’s drug misses key goal in Prader-Willi trial

Soleno Therapeutics has unveiled new data showing that its diazoxide choline controlled release (DCCR) tablets failed to reduce hyperphagia – or an abnormal desire for food – in patients with Prader-Willi syndrome.

COVID-19 Update

Dear Patients and Families, On behalf of the University of Florida Pediatric Endocrine team I would like to update you on the current COVID-19 situation. First and foremost, please know that our team is available for you and your child during this public health emergency. Second, I want to…

Pediatric Endocrinology #19

UF Health Shands Children’s Diabetes & Endocrinology Hospital ranked #19 by U.S. News and World Report.